SpringLeaf Therapeutics Garners $4,000,000 Series B Funding Round

  • Feed Type
  • Date
    7/8/2011
  • Company Name
    SpringLeaf Therapeutics
  • Mailing Address
    8 St. Mary’s Street Boston, MA 02215
  • Company Description
    SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics.
  • Website
    http://www.springleaftx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    With the support of our new and existing investors, SpringLeaf is well positioned to advance our proprietary program, transforming the way patients are treated.
  • M&A Terms
  • Venture Investor
    Excel Venture Management

By posting a comment, you agree to our terms and conditions.